Degree of healing and healing-associated factors of endoscopic submucosal dissection-induced ulcers after pantoprazole therapy for 4 weeks
- PMID: 19005762
- DOI: 10.1007/s10620-008-0506-5
Degree of healing and healing-associated factors of endoscopic submucosal dissection-induced ulcers after pantoprazole therapy for 4 weeks
Abstract
Background: There is no consensus regarding the degree of healing of endoscopic submucosal dissection (ESD)-induced ulcers and the optimal duration of proton pump inhibitor (PPI) treatment.
Aim: To evaluate the degree of healing and the factors associated with healing of ESD-induced ulcers after PPI therapy for 4 weeks.
Methods: Fifty-six patients who underwent complete ESD for adenoma or early gastric cancer were enrolled. All patients underwent follow-up endoscopy to evaluate the degree of ulcer healing after pantoprazole therapy (40 mg per day) for 4 weeks. We evaluated change in size of ESD-induced ulcers between baseline and 4 weeks, and correlated relevant factors with degree of healing of small and large ulcers.
Results: At follow-up, 28 (50%) patients had large ulcers (area > 10 mm(2)). Ulcer size at 4 weeks was closely correlated with initial ulcer size (P < 0.001) and abruptly increased when initial ulcer size was larger than 4 cm. Comorbidity, procedure time, and initial specimen size were significantly associated with healing rate, but multivariate analysis showed that initial ulcer size was the only significant parameter (P < 0.015).
Conclusions: Healing degree of ESD-induced ulcers at 4 weeks is dependent on initial ulcer size, indicating that duration of treatment with PPI should be dependent on initial ulcer size.
Similar articles
-
Prospective single-arm trial of two-week rabeprazole treatment for ulcer healing after gastric endoscopic submucosal dissection.Dig Endosc. 2012 Mar;24(2):110-6. doi: 10.1111/j.1443-1661.2011.01178.x. Epub 2011 Jul 13. Dig Endosc. 2012. PMID: 22348835
-
Optimal duration of proton pump inhibitor in the treatment of endoscopic submucosal dissection-induced ulcers: a retrospective analysis and prospective validation study.Dig Dis Sci. 2012 Feb;57(2):429-34. doi: 10.1007/s10620-011-1941-2. Epub 2011 Oct 15. Dig Dis Sci. 2012. PMID: 22001942 Clinical Trial.
-
Effective healing of endoscopic submucosal dissection-induced ulcers by a single week of proton pump inhibitor treatment: a retrospective study.BMC Res Notes. 2015 Apr 15;8:150. doi: 10.1186/s13104-015-1111-2. BMC Res Notes. 2015. PMID: 25889379 Free PMC article.
-
Comparative efficacy of various anti-ulcer medications after gastric endoscopic submucosal dissection: a systematic review and network meta-analysis.Surg Endosc. 2019 Apr;33(4):1271-1283. doi: 10.1007/s00464-018-6409-4. Epub 2018 Aug 30. Surg Endosc. 2019. PMID: 30167955
-
Role of mucoprotective agents in endoscopic submucosal dissection-derived ulcers: A systematic review.J Gastroenterol Hepatol. 2018 Dec;33(12):1948-1955. doi: 10.1111/jgh.14305. Epub 2018 Jun 25. J Gastroenterol Hepatol. 2018. PMID: 29870582
Cited by
-
Two-week treatment with proton pump inhibitor is sufficient for healing post endoscopic submucosal dissection ulcers.World J Gastroenterol. 2014 Nov 21;20(43):16318-22. doi: 10.3748/wjg.v20.i43.16318. World J Gastroenterol. 2014. PMID: 25473190 Free PMC article. Clinical Trial.
-
Clinical practice guideline for endoscopic resection of early gastrointestinal cancer.Intest Res. 2021 Apr;19(2):127-157. doi: 10.5217/ir.2020.00020. Epub 2020 Oct 13. Intest Res. 2021. PMID: 33045799 Free PMC article.
-
Rebamipide with Proton Pump Inhibitors (PPIs) versus PPIs Alone for the Treatment of Endoscopic Submucosal Dissection-Induced Ulcers: A Meta-analysis.Biomed Res Int. 2020 Sep 28;2020:7196782. doi: 10.1155/2020/7196782. eCollection 2020. Biomed Res Int. 2020. PMID: 33062694 Free PMC article.
-
Randomized Controlled Trial Comparing the Effects of Vonoprazan Plus Rebamipide and Esomeprazole Plus Rebamipide on Gastric Ulcer Healing Induced by Endoscopic Submucosal Dissection.Intern Med. 2019 Jan 15;58(2):159-166. doi: 10.2169/internalmedicine.1146-18. Epub 2018 Sep 12. Intern Med. 2019. PMID: 30210115 Free PMC article. Clinical Trial.
-
A matched case-control study of a novel Acid-pump antagonist and proton-pump inhibitor for the treatment of iatrogenic ulcers caused by endoscopic submucosal dissection.Gut Liver. 2010 Mar;4(1):25-30. doi: 10.5009/gnl.2010.4.1.25. Epub 2010 Mar 25. Gut Liver. 2010. PMID: 20479909 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous